Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Porta

Showing results (111-120 of 229) with videos related to

Pageof 23
Sort By:
Intervirology|January 1, 1996
The development of cowpea mosaic virus as a potential source of novel vaccinesC Porta, V E Spall, T Lin, et al.
Israel Journal of Medical Sciences|July 1, 1973
Immunological aspects of amyloidosisE Clerici, G Garotta, C Porta, et al.
Haematologica|July 1, 1992
Chronic Epstein-Barr virus infectionE B Pallavicini, G Brambilla, C Porta, et al.
European Journal of Nutrition|June 24, 2011
Effects of creatine in a rat intestinal model of ischemia/reperfusion injuryM N Orsenigo, C Porta, C Sironi, et al.
Minerva Chirurgica|October 15, 1983
[Treatment of obstructive jaundice with transparieto-hepatic drainage. Personal experience]M Viganò, R Caprotti, M Castoldi, et al.
La Radiologia Medica|October 1, 1991
[Embolization of popliteal artery aneurysm with Gianturco coils and angiographic guide wires]T Meloni, G Rossi, P Carbonatto, et al.
Nature|January 16, 1992
Identification of a Fab interaction footprint site on an icosahedral virus by cryoelectron microscopy and X-ray crystallographyG J Wang, C Porta, Z G Chen, et al.
Haematologica|March 7, 2000
Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patientsM Moroni, C Porta, M De Amici, et al.
Oncology Reports|April 18, 2000
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes and granulocyte colony-stimulating factor in breast cancer patientsM Danova, C Porta, S Ferrari, et al.
Cancer Chemotherapy and Pharmacology|June 8, 2001
Sequential intrahepatic and systemic fluoropyrimidine-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II studyC Porta, M Danova, S Accurso, et al.
Pageof 23

Showing results (111-120 of 229) with videos related to

Sort By:
Pageof 23
Intervirology|January 1, 1996
The development of cowpea mosaic virus as a potential source of novel vaccinesC Porta, V E Spall, T Lin, et al.
Israel Journal of Medical Sciences|July 1, 1973
Immunological aspects of amyloidosisE Clerici, G Garotta, C Porta, et al.
Haematologica|July 1, 1992
Chronic Epstein-Barr virus infectionE B Pallavicini, G Brambilla, C Porta, et al.
European Journal of Nutrition|June 24, 2011
Effects of creatine in a rat intestinal model of ischemia/reperfusion injuryM N Orsenigo, C Porta, C Sironi, et al.
Minerva Chirurgica|October 15, 1983
[Treatment of obstructive jaundice with transparieto-hepatic drainage. Personal experience]M Viganò, R Caprotti, M Castoldi, et al.
La Radiologia Medica|October 1, 1991
[Embolization of popliteal artery aneurysm with Gianturco coils and angiographic guide wires]T Meloni, G Rossi, P Carbonatto, et al.
Nature|January 16, 1992
Identification of a Fab interaction footprint site on an icosahedral virus by cryoelectron microscopy and X-ray crystallographyG J Wang, C Porta, Z G Chen, et al.
Haematologica|March 7, 2000
Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patientsM Moroni, C Porta, M De Amici, et al.
Oncology Reports|April 18, 2000
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes and granulocyte colony-stimulating factor in breast cancer patientsM Danova, C Porta, S Ferrari, et al.
Cancer Chemotherapy and Pharmacology|June 8, 2001
Sequential intrahepatic and systemic fluoropyrimidine-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II studyC Porta, M Danova, S Accurso, et al.
Pageof 23